About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in New York | 76 Studies

Clinical Trials Alzheimer's DiseaseNew York

Alzheimer's Disease Clinical Trials in New York

Find 76 clinical trials for alzheimer's disease near New York, New York. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 76 trials

CompletedSUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a StudyThis is a phase 2a, proof-of-concept, 26-week, double-blind, multicenter, randomized, parallel group, placebo-controlled study to compare the efficacy and safety of treatment with…NCT02580305·Phoenix, Arizona and 70 others

Alzheimer's Disease Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingA Study of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseThe purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment \[MCI\] to…NCT07169578·Birmingham, Alabama and 141 others

CompletedStudy of Melatonin: Sleep Problems in Alzheimer's DiseaseThis protocol is a multicenter clinical trial of melatonin for sleep disturbances associated with Alzheimer's disease (AD).NCT00000171·Tucson, Arizona and 30 others

TerminatedPiromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's DiseaseRandomized efficacy and safety study of piromelatine 20 mg versus placebo in participants with mild dementia due to Alzheimer's disease (AD) who are 2:107,510,000-107,540,000…NCT05267535·Costa Mesa, California and 36 others

RecruitingRobotic-Enabled Microsurgical Intervention for Neurodegenerative DiseaseThe objective of this investigational device exemption (IDE) study is to evaluate the safety and feasibility of using the Symani System and microsurgical techniques in the deep…NCT07178210·Palo Alto, California and 2 others

CompletedMemantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver TrainingThe purpose of this study is to determine whether a comprehensive, individualized management approach with caregiver training and medication with memantine will alleviate symptoms…NCT00120874·New York, New York

CompletedAntipsychotic Discontinuation in Alzheimer's DiseaseIn patients with Alzheimer's disease (AD) who respond to antipsychotic treatment of psychosis and/or agitation/aggression, the relapse risk after discontinuation is not…NCT00417482·Tuscaloosa, Alabama and 6 others

TerminatedA Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease DementiaThe main purpose of this study is to evaluate the efficacy of the study drug known as lanabecestat in participants with mild Alzheimer's disease (AD) dementia.NCT02783573·Phoenix, Arizona and 261 others

CompletedAlzheimer's Disease Neuroimaging Initiative 3Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has been realized in informing the design of therapeutic trials in AD.NCT02854033·Birmingham, Alabama and 58 others

UnknownPredictors of Cognitive Decline in Normal AgingThe goal of this project is to develop an early diagnostic test for Alzheimer's disease (AD) by monitoring loss of neurons and brain size reductions over a period of five years.NCT00094939·New York, New York

CompletedFollow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05This study will evaluate longitudinal change of tau deposition as measured by flortaucipir F 18 uptake over time.NCT02795780·Phoenix, Arizona and 21 others

TerminatedA Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 FlutemetamolThis is an investigator-initiated study comparing two types of FDA-approved anti-depressants, Escitalopram and Venlafaxine, to placebo, in order to determine if these medications…NCT03274817·New York, New York

Active not recruitingA Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADThe goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer's disease in adults aged 55-85.NCT06709014·Chandler, Arizona and 77 others

RecruitingTrial-Ready Cohort-Down Syndrome (TRC-DS)The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), between the ages of 25-55, into a trial ready cohort (TRC)…NCT04165109·Phoenix, Arizona and 21 others

CompletedEARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)12-week, open-label study to evaluate the effectiveness and safety of donepezil hydrochloride in Hispanic patients with mild to moderate Alzheimer's Disease (AD) in the U.S.NCT00230568·Phoenix, Arizona and 34 others

CompletedEstrogen Hormone ProtocolEstrogen is a hormone that is dominant in the female reproductive system. In women, most estrogen is produced by the ovaries.NCT00000177·Birmingham, Alabama and 24 others

CompletedHuperzine A in Alzheimer's DiseaseThe present study will evaluate the safety and efficacy of the Chinese herb huperzine A in the treatment of Alzheimer's disease (AD) in a randomized controlled trial of its effect…NCT00083590·Birmingham, Alabama and 28 others

TerminatedA Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease PatientsThe purpose of this study is to assess the long-term safety and tolerability of bapineuzumab in subjects with Alzheimer Disease who participated in study 3133K1-3001(NCT00676143).NCT00998764·Birmingham, Alabama and 183 others

RecruitingA Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationThe purpose is to evaluate the biomarker effect, safety, and tolerability of investigational study drugs in participants who are known to have an Alzheimer's disease (AD)-causing…NCT05552157·Birmingham, Alabama and 36 others

CompletedVITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)The purpose of this study is to determine whether reduction of homocysteine levels with high-dose folate (folic acid), B6, and B12 supplementation will slow the rate of cognitive…NCT00056225·Birmingham, Alabama and 37 others

PreviousPage 3 of 4Next

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia